Nanopass™ 34G
Needle for Pen Injectors
Less pain1, every day.
The world's thinnest double tapered pen needle2
with a diameter of only 34G.
The world's thinnest double tapered pen needle2
with a diameter of only 34G.
false
Nanopass™ 34G pen needle is intended for use with a pen injector device for the subcutaneous injection of drugs including insulin and human growth hormone.
Diabetes patients have long been in search of less painful1 insulin injection. Terumo has made this possible with advanced Nanopass™ 34G – the world's thinnest double tapered pen needle2 with a diameter of only 34G. The world's first3 34G!
neutrals-100
pd-y-2
Features
2
neutrals-100
pd-y-2
World's thinnest double tapered pen needle 34G2
Nanopass™ 34G is 22% thinner than 32G.
- Pain is primarily related to needle thickness. There are 100-200 pain receptors per cm² human skin surface. Nanopass™ 34G decreases the probability of touching the pain receptors and therefore makes the insulin injection less painful1.
- Nanopass™ 34G causes less skin trauma than larger needle sizes, which results in less pain1.
grid-texts-60
text-vertical-center
image-media-type
default-aspect-ratio
media-left
true
Asymmetric bevel4
The unique asymmetric bevel4 of Nanopass™ 34G cuts the skin instead of puncturing it.
This decreases the resistance while penetrating the skin.
Another step towards less painful1 insulin injection.
grid-texts-60
text-vertical-center
image-media-type
default-aspect-ratio
media-right
true
Slim double tapered shape4
The patented slim double tapered needle shape4 reduces the insulin injection
force significantly.
Although the needle tip is 34G, Nanopass™ 34G provides less injection force than
a conventional 32G pen needle2.
Nanopass™ 34G combines less painful1 injection with easy handling.
grid-texts-60
text-vertical-center
image-media-type
default-aspect-ratio
media-left
true
pd-y-2
Compatibility
2
neutrals-100
pd-y-2
pd-y-8
Item Specifications
2
neutrals-100
pd-y-2
All images, sizes, colors and shapes are indicative only and may differ in real life.
All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION, its affiliates, or unrelated third parties.
neutrals-100
pd-y-16
pd-y-16
This product is also available for pharmaceutical professionals.
Nanopass™ Pen needles are part of Terumo Pharmaceutical Solutions Division (PSD) portfolio.
Nanopass™ Pen needles are part of Terumo Pharmaceutical Solutions Division (PSD) portfolio.
neutrals-100
Visit Terumo PSD
link
pd-y-16
pd-y-2
References
2
neutrals-100
pd-y-2
text
Asakura T., Seino H., 2013, Jpn J Med Pharm Sci 69(1):137-146. & Asakura T., 2013, Jpn J Med Pharm Sci 69(1):147-155.
text
Based on research by Terumo Corporation in November 2020.
text
Terumo Corporation launched Nanopass™ 34G in September 2012.
Text
text
Patented technology.
Related Products
2
neutrals-100
variation-3-carousel
true
variation-3-carousel
Nanopass™ 32.5G
Needle for Pen Injectors
variation-3-carousel
Medisafe Fit Smile™
Blood Glucose Meter
variation-3-carousel
Medisafe Fit™
Blood Glucose Meter
variation-3-carousel
Medisafe Fit™
Test TIP
variation-3-carousel
Medisafe Finetouch™ II
Lancing Device
variation-3-carousel
Terumo Finetouch™
Lancet